For: | Ibrahim AM, Wang YH. Viro-immune therapy: A new strategy for treatment of pancreatic cancer. World J Gastroenterol 2016; 22(2): 748-763 [PMID: 26811622 DOI: 10.3748/wjg.v22.i2.748] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i2/748.htm |
Number | Citing Articles |
1 |
Elaine Tan, Bassel El-Rayes. Pancreatic Cancer and Immunotherapy: Resistance Mechanisms and Proposed Solutions. Journal of Gastrointestinal Cancer 2019; 50(1): 1 doi: 10.1007/s12029-018-0179-z
|
2 |
Mengyu Feng, Guangbing Xiong, Zhe Cao, Gang Yang, Suli Zheng, Xujun Song, Lei You, Lianfang Zheng, Taiping Zhang, Yupei Zhao. PD-1/PD-L1 and immunotherapy for pancreatic cancer. Cancer Letters 2017; 407: 57 doi: 10.1016/j.canlet.2017.08.006
|
3 |
Shuangshuang Lu, Tasqeen Ahmed, Pan Du, Yaohe Wang. Genomic Variations in Pancreatic Cancer and Potential Opportunities for Development of New Approaches for Diagnosis and Treatment. International Journal of Molecular Sciences 2017; 18(6): 1201 doi: 10.3390/ijms18061201
|
4 |
Jia-qiao Fan, Meng-Fei Wang, Hai-Long Chen, Dong Shang, Jugal K. Das, Jianxun Song. Current advances and outlooks in immunotherapy for pancreatic ductal adenocarcinoma. Molecular Cancer 2020; 19(1) doi: 10.1186/s12943-020-01151-3
|
5 |
Qiang Yan, Wen-Bin Yuan, Xu Sun, Ming-Jie Zhang, Feng Cen, Shi-Yu Zhou, Wan-Bo Wu, Yong‑Can Xu, Li-Hui Tong, Zhi-Hong Ma. Asparaginyl endopeptidase enhances pancreatic ductal adenocarcinoma cell invasion in an exosome-dependent manner and correlates with poor prognosis. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4318
|
6 |
Yuedi Ding, Jun Fan, Lili Deng, Ying Peng, Bin Zhou, Biao Huang. <p>Evaluation of Tumor Specificity and Immunity of Thymidine Kinase-Deleted Vaccinia Virus Guang9 Strain</p>. OncoTargets and Therapy 2020; : 7683 doi: 10.2147/OTT.S260288
|
7 |
Qiang Yan, Chenming Ni, Yingying Lin, Xu Sun, Zhenhua Shen, Minjie Zhang, Shuwen Han, Jiemin Shi, Jing Mao, Zhe Yang, Weilin Wang. ELK1 Enhances Pancreatic Cancer Progression Via LGMN and Correlates with Poor Prognosis. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.764900
|
8 |
Yuedi Ding, Jun Fan, Lili Deng, Biao Huang, Bin Zhou. Antitumor efficacy of cytosine deaminase-armed vaccinia virus plus 5-fluorocytosine in colorectal cancers. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01340-6
|
9 |
Kai Sun, Xue-de Zhang, Xiao-yang Liu, Pei Lu. YAP1 is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Pancreatic Cancer. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.625731
|
10 |
Zeynep Nur Senturk, Isilay Akdag, Bahar Deniz, Ayca Sayi-Yazgan. Pancreatic cancer: Emerging field of regulatory B-cell-targeted immunotherapies. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1152551
|
11 |
Yuan Qiao, Li-Jun Yan, Chao Yan. Sauchinone inhibits hypoxia-induced epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma cells through the Wnt/β-catenin pathway. Anti-Cancer Drugs 2020; 31(9): 918 doi: 10.1097/CAD.0000000000000956
|
12 |
Jingchang Zhang, Renfeng Li, Shuai Huang. The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.951019
|
13 |
Songyu Guo, Zhenxia Wang. Unveiling the immunosuppressive landscape of pancreatic ductal adenocarcinoma: implications for innovative immunotherapy strategies. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1349308
|